DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC ERGK010 VCAP 120H D01 PRKACG.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

VCAP

Subject (Entity type)

Project:

L1000-Phase1

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Disease:

prostate adenocarcinoma

Disease (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC ERGK010 VCAP 120H D01 PRKACG

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Anatomy:

prostate gland

Anatomy (Entity type)

Uncompressed Size In Bytes:756 KB

Size In Bytes:277 KB

Sha256:737aa65c8101aae2c0b44aa5947b784a5b0d9fa972177f0646666aea52bd1ece

Persistent Id:drs://drs.lincs-dcic.org/1b22f81e5f30e20b0fd30b489557ff1a

Mime Type:application/gzip

Md5:1b22f81e5f30e20b0fd30b489557ff1a

Filename:L1000_LINCS_DCIC_ERGK010_VCAP_120H_D01_PRKACG.tsv.gz

Creation Time:2017-03-03T00:00:00

Access Url:

drs://drs.lincs-dcic.org/1b22f81e5f30e20b0fd30b489557ff1a

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC ERGK010 VCAP 120H D01 PRKACG Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC ERGK010 VCAP 120H D01 PRKACG

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.